Louise Rodino-Klapac

Louise Rodino-Klapac

Chief Tech/Sci/R&D Officer at SAREPTA THERAPEUTICS, INC.

Net worth: 975 059 $ as of 31/05/2026

48 year
Health Technology
Consumer Services
Commercial Services

Profile

Founder of Myonexus Therapeutics, Inc., Louise Rodino-Klapac is on the board of Alliance for Regenerative Medicine and Aavantibio, Inc. and Chief Scientific Officer & Executive VP at Sarepta Therapeutics, Inc., Member of American Academy of Neurology and Member of American Society of Gene & Cell Therapy. She previously occupied the position of Chief Scientific Officer at Myonexus Therapeutics, Inc. and Head-Laboratory for Gene Therapy Research at Nationwide Children's Hospital. She received an undergraduate degree from King's College (Pennsylvania) and a doctorate from The Ohio State University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
08/04/2026 54,564 ( 0.05% ) 975 059 $ 31/05/2026

Louise Rodino-Klapac active positions

CompaniesPositionStart
SAREPTA THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 14/12/2020
Director/Board Member 01/01/2021
Corporate Officer/Principal -
Corporate Officer/Principal -

Former positions of Louise Rodino-Klapac

CompaniesPositionEnd
Corporate Officer/Principal 01/06/2019
Founder 01/04/2019
Director/Board Member -
See the detail of Louise Rodino-Klapac's experience

Training of Louise Rodino-Klapac

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

43

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Consumer Services

Consumer Services

Commercial Services

Health Services

Health Services

Commercial Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Louise Rodino-Klapac
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!